Sonia Appleby’s employment tribunal against the Tavistock and Portman Trust begins today. Ms Appleby is the Trust’s Safeguarding Lead for Children. Details of her claim emerged after Newsnight reported staff at GIDS claimed they’d been discouraged from seeking her advice. ⬇️
Employment Judge Goodman (EJG) is presiding. Discussing now whether and what documents will be placed in the public domain.
Discussion about timetable for witnesses and which side will go first in the hearing. Yvette Genn (YG) is acting on behalf of the Tavistock. Anya Palmer (AP) acts on behalf of Sonia Appleby
Employment judge Goodman (EJG) suggests easier if claimant goes first
Unlikely evidence will start today because members of tribunal need time to read through bundle
Short pause while Sonia Appleby’s team discuss an application being considered.
EJG - employment judge Goodman
SA - Sonia Appleby
YG - Yvette Genn, counsel for Tavistock
AP - Anya Palmer, counsel for SA
AP - wants names of interview transcripts with Dr Sinha to be unredacted. (HB note: These are interview transcripts conducted as part of GIDS review in 2018/19)
AP says claimant in ‘invidious position’ having to guess who is talking about her.
Counsel want names of five managers unredacted along with one other.
AP unable to satisfy herself that everything ‘relevant’ in transcripts has been unredacted
AP: “There certainly looks like there is relevant information behind the redaction”
“We are not happy with the state Of the redactions.”
AP quotes from another transcript of interview with Tavi manager which says that there were “concerns” about claimant’s “approach” to GIDS cases. Transcript says “some may have felt it was a bit transphobic.” AP makes argument that SA’s team needs to know identity of manager
AP says that everything contained in transcripts is relevant to SA’s claim
SA’s ‘whistleblowing’ starts in 2017. Several protected disclosures take place in 2017 and 2018. Alleged detriments begin in 2018
Technical difficulties.
YG “takes great exception” to AP’s comments
YG says it was agreed on what basis transcripts would be used and which terms would be looked at eg
Claimants name, ‘safeguarding lead.’
This explains docs in the way you see them - the complaint that there are bits missing is because of the approach agreed, not Tavi action.
YG explains that anonymity of those who spoke to Dr Sinha as part of GIDS review were assured of anonymity
YG says ‘very dispiriting’ that nothing explained in application as to why certain interviewees should be disclosed. Stresses again the importance of anonymity.
YG says claimant hasn’t established ‘necessity’ to disclose
YG: “Risk of expanding out” to matters that are not of concern to this tribunal. May be other issues at the Trust, but the scope of the tribunal is pretty narrow. It’s about SA’s actions, not what anyone else may have disclosed.
“Claimant seeking to expand out huge numbers of people who were promised confidentiality…wholly wrong to suggest the trust has done anything underhand or mischievous…”
YG: “no good reason why these individuals should be identified or why there should be any further exploration into what they say.”
AP: press are entitled to see witness statements and anything referred to in those. Will take considerable amount of work to redact all names of those mentioned who are not witnesses
AP: a ‘minimalist approach’ to redaction should be taken
ETJ: no reason to anonymise witnesses.
Judge discussing how other people will be referred to.
Discussion between all parties on level of redaction to be used throughout proceedings.
EJG: not practical to undergo extensive redaction now, but tribunal will exercise caution in naming others in its judgement.
YG says that redacted parts of transcripts don’t contain the search terms agreed in previous order agreed by Judge Norris and are not to do with claimant’s concerns.
YG insists there is nothing else contained in documents that is relevant.
AP challenges disclosure made by respondent
EJG: unredacted statements of six Tavi employees mentioned to be sent confidentially to SA’s counsel. Does not imply anything wrong with disclosure but to ensure public confidence
Hearing adjourned until tomorrow morning.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
NEW: A judgement has been handed down by Family Division of the High Court this morning on question whether, in light of Keira Bell ruling on under 16s being ‘unlikely’ to provide informed consent to puberty blockers, parents can consent on their behalf. @deb_cohen 1/
It’s a thorough and complex judgement, but here are some points. 1) Parents CAN give consent: Whether or not a child can provide consent to blockers, “parents retain the parental right to consent to that treatment,” judge said. PBs should not have a special exemption. 2/
Mrs Justice Lieven: “The factors identified in Bell, which I fully agree with, do not justify removing the parental right to consent. The gravity of the decision to consent to PBs is very great, but it is no more enormous than consenting to a child being allowed to die...” 3/
This morning there was a preliminary hearing of the Bell v Tavistock appeal (re: whether young people can give informed consent to treatment with puberty blockers), where the court decided whether there could be any new interveners in the case 1/
The hearing confirmed that those who intervened in the original case – University College London Hospitals Trust, Leeds Teaching Hospitals Trust, and Transgender Trend – would all be allowed to do so again in the appeal. 2/
In response to a joint application made by Stonewall, Gendered Intelligence, the Endocrine Society and Brook – the court ruled Stonewall were not granted permission to intervene, but the remaining three have been. Association of Lawyers for Children will also be interveners. 3/
NEW:Tavistock Gender Identity Development Service (GIDS) Executive - leadership team - to be ‘disbanded’ in response to CQC’s ‘inadequate’ rating of service & decision in Keira Bell judicial review on whether under 16s can consent to treatment with puberty blockers @deb_cohen 1/
“In response to the CQC report and the breadth of existing actions flowing from the Judicial Review judgment we are proposing to take immediate action to strengthen management arrangements for the service and increase our clinical and operational capacity to deliver change” 2/
This will see “a new Interim GIDS Management Board, chaired by the Divisional Director for Gender. This will replace existing senior management structures in GIDS and will provide a single point of accountability for both improvement programmes and existing service delivery.” 3/
NEW: Tavistock’s Gender Identity Development Service rated ‘inadequate’ by CQC after inspecting GIDS in autumn. CQC say inspection prompted by concerns reported by healthcare professionals & Children’s Commissioner, who’d been given evidence by me&@deb_cohen for @BBCNewsnight. 1/
This is a long thread. Bear with it if you can. Inadequate is the CQC’s lowest safety rating. This means that a service is ‘performing badly.’ GIDS’ smaller clinic based in Leeds was also rated inadequate. GIDS had been rated good at its previous CQC inspection in 2016. 2/
Since then, concerns have been raised about the service: @BBCNewsnight revealed how some GIDS staff had raised serious concerns about safeguarding, the speed of assessments, and whether patients’ other difficulties were always adequately explored. tinyurl.com/y7frzsr6 3/
Court has resumed after lunch. Barrister for endocrinologists explains:
For UCL, median age for blockers 14.6, for cross sex hormones 17.4, youngest 10
For Leeds, median age for blockers 16, cross sex hormones 17.2, youngest 12
Of 145 patients referred to Leeds, 38 experienced delays to treatment. On two occasions pressure was seen to be coming from parent and choice not freely made. Barrister says evident there is no immediate access to treatment after referral
Barrister for endocrinologists says the relevant information on risks/benefits is very different for stage 1 (blockers) and 2 (cross sex hormones). ‘It’s no answer to say the majority of patients do go from stage 1 to stage 2.’